Glycopyrrolate Oral Solution Approved

7/30/2010

The FDA approved Shionogi Pharma’s Cuvposa (glycopyrrolate) oral solution for the treatment of chronic severe drooling caused by neurologic disorders in children 3 to 16 years of age.

Clin-eguide™ is an online clinical decision support tool that provides the most accurate evidence-based information for health care providers in the clinical setting. It integrates trusted content from Ovid, Facts & Comparisons®, and Lippincott Williams and Wilkins, as well as other premier publishers.